BARTOLETTI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 5.325
EU - Europa 3.905
AS - Asia 1.910
AF - Africa 238
SA - Sud America 33
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.427
Nazione #
US - Stati Uniti d'America 5.304
GB - Regno Unito 1.064
IT - Italia 739
SE - Svezia 706
CN - Cina 546
SG - Singapore 531
DE - Germania 459
VN - Vietnam 438
IN - India 227
IE - Irlanda 191
FR - Francia 130
RU - Federazione Russa 120
BG - Bulgaria 112
CH - Svizzera 75
TG - Togo 75
CI - Costa d'Avorio 73
JO - Giordania 56
ZA - Sudafrica 53
UA - Ucraina 51
EE - Estonia 47
ES - Italia 45
FI - Finlandia 38
BE - Belgio 37
NG - Nigeria 28
ID - Indonesia 27
BR - Brasile 18
IR - Iran 18
NL - Olanda 16
CA - Canada 14
HK - Hong Kong 11
RO - Romania 11
AT - Austria 10
AU - Australia 10
HR - Croazia 10
KR - Corea 10
GR - Grecia 9
PL - Polonia 8
JP - Giappone 7
PK - Pakistan 6
MY - Malesia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
CZ - Repubblica Ceca 4
PH - Filippine 4
PT - Portogallo 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
CL - Cile 3
EC - Ecuador 3
HN - Honduras 3
PE - Perù 3
TH - Thailandia 3
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
LY - Libia 2
MN - Mongolia 2
MX - Messico 2
NO - Norvegia 2
PA - Panama 2
TR - Turchia 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
Totale 11.427
Città #
Southend 1.000
Chandler 646
Fairfield 597
Singapore 479
Ashburn 397
Woodbridge 267
Wilmington 266
Houston 250
Seattle 237
Ann Arbor 225
Princeton 217
Cambridge 211
Dong Ket 206
Dublin 190
Bologna 165
Santa Clara 165
Boardman 139
Sofia 109
New York 95
Lomé 75
Abidjan 73
Berlin 66
Bern 62
Westminster 60
Nanjing 59
Amman 56
Redmond 55
Bremen 54
Padova 44
San Diego 43
Saint Petersburg 40
Beijing 39
Brussels 35
Jinan 35
Turin 34
Falls Church 33
Helsinki 31
Abeokuta 28
Milan 28
Redwood City 27
Shenyang 27
Florence 26
Des Moines 25
Jakarta 25
Shanghai 24
Hebei 21
Rome 21
Nanchang 20
Olalla 20
Bühl 18
Los Angeles 18
Changsha 17
Dearborn 17
Ningbo 16
Chicago 15
Washington 15
London 14
San Francisco 14
Guangzhou 13
Zhengzhou 13
Jiaxing 12
Haikou 11
Verona 11
Leganés 10
Paris 10
Parma 10
São Paulo 10
Toronto 10
Hangzhou 9
Duncan 8
Hong Kong 8
Medford 8
Mülheim 8
Norwalk 8
Shenzhen 8
Taizhou 8
Amsterdam 7
Jacksonville 7
Lappeenranta 7
Leawood 7
Mountain View 7
Pisa 7
Brescia 6
Costa Mesa 6
Imola 6
Kunming 6
Moscow 6
Naples 6
Sala Bolognese 6
Taiyuan 6
Tianjin 6
Boydton 5
Fremont 5
Genoa 5
Incheon 5
Rimini 5
San Jose 5
Shijiazhuang 5
Vicenza 5
Vienna 5
Totale 7.507
Nome #
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 515
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 193
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 186
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 179
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 176
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 174
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 168
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 164
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 158
Bloodstream infections in patients with liver cirrhosis 153
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 148
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 146
Advances in the therapy of bacterial bloodstream infections 145
null 142
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 140
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 138
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 135
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 134
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 132
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 132
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 132
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 131
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 130
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 130
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 130
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 129
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 129
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 128
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 128
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 126
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 122
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 121
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 119
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 117
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 116
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 116
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 115
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 114
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 113
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 113
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 111
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 109
The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: A prospective six-year experience 107
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 106
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 106
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 105
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 104
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 104
null 102
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 102
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 100
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 99
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 99
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 99
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 98
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 97
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 97
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 96
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 96
Opportunistic infections in end stage liver disease 96
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 96
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 93
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 91
null 91
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 91
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 91
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 90
null 90
null 88
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 88
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 87
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 84
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 84
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 83
Procalcitonin-guided antibiotic therapy: An expert consensus 83
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 79
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 78
null 77
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 77
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 77
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 77
null 76
Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy 72
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 71
The Gut Microbiota of Critically Ill Patients With COVID-19 69
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 68
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 65
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 65
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 62
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 61
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 61
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis 58
ESCMID COVID-19 living guidelines: drug treatment and clinical management 58
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 57
null 56
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 54
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 53
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 52
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply 51
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 50
Totale 10.904
Categoria #
all - tutte 33.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.550 0 0 0 0 193 196 257 310 263 143 79 109
2020/20211.743 213 99 77 55 147 75 65 130 155 133 97 497
2021/20222.528 182 78 98 203 170 136 105 220 134 301 476 425
2022/20232.764 254 331 152 368 212 212 85 204 493 123 187 143
2023/20241.049 67 150 63 102 74 234 66 79 43 79 52 40
2024/20251.321 149 388 239 262 283 0 0 0 0 0 0 0
Totale 11.832